MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2018 International Congress

    Physiological effects of Botulinum Toxin therapy in Primary Cervical Dystonia

    W. Deeb, W. Hu, A. Wagle Shukla (Gainesville, FL, USA)

    Objective: To examine the physiological effects of botulinum toxin (BoNT) therapy, as measured by paired-pulse transcranial magnetic stimulation (TMS), in patients with primary cervical dystonia…
  • 2017 International Congress

    Regional differences may influence the drivers of change in Toronto Western Spasmodic Rating Scale (TWSTRS) scores following botulinum toxin treatment: Analysis of an international observational study

    V. Misra, D. Charles, T.M. Chung, C. Colosimo, S. Om, P. Maisonobe (London, United Kingdom)

    Objective: Investigate the drivers for change in Toronto Western Spasmodic Rating Scale (TWSTRS) scores in subjects with cervical dystonia (CD) following a single injection of…
  • 2017 International Congress

    Cost-utility analysis of flexible interval incobotulinumtoxinA versus onabotulinumtoxinA in the management of blepharospasm and cervical dystonia in Ontario, Canada.

    M.-E. Gendron, M.-E. Gendron, R. Kazerooni (Burlington, ON, Canada)

    Objective: To carry out a cost-utility analysis for IncoBTX administered with flexible treatment intervals compared to OnaBTX in the management of BL and CD from…
  • 2017 International Congress

    Impact of injection interval on patient satisfaction in the routine treatment of cervical dystonia with abobotulinumtoxinA

    R. Trosch, V. Misra, P. Maisonobe, S. Om (Farmington Hills, MI, USA)

    Objective: Evaluate the impact of injection interval on patient satisfaction with abobotulinumtoxinA (AboBoNT-A; Dysport®) over 1 injection cycle in patients with cervical dystonia (CD). Background:…
  • 2017 International Congress

    Injection guidance use in the management of cervical dystonia with botulinum toxin

    D. Charles, T.M. Chung, C. Colosimo, V. Misra, P. Maisonobe, S. Om (Nashville, TN, USA)

    Objective: Investigate the use of injection guidance techniques and their impact on patient outcomes in the routine management of cervical dystonia (CD) with botulinum neurotoxin…
  • 2017 International Congress

    Which factors predict patient satisfaction with botulinum toxin treatment for cervical dystonia?

    C. Colosimo, V. Misra, D. Charles, T.M. Chung, S. Om, P. Maisonobe (Terni, Italy)

    Objective: Investigate which factors influence patient satisfaction with botulinum neurotoxin type A (BoNT-A) treatment for cervical dystonia (CD) in routine practice. Background: We have previously…
  • 2017 International Congress

    Clinical and demographics of cervical dystonia related to the direction of the neck movement

    K. Asanuma (Kyoto, Japan)

    Objective: The objectives of this report is to survey whether the type of torticollis (i.e. rotation, retrocolis and anterocolis) is related to the clinical characteristics…
  • 2017 International Congress

    Clinical effects are persistent at the end of one abobotulinumtoxinA injection cycle in cervical dystonia – results from a meta-analysis of 1091 subjects

    R. Trosch, V. Misra, P. Maisonobe, S. Om (Farmington Hills, MI, USA)

    Objective: Evaluate the impact of one injection cycle of abobotulinumtoxinA (AboBoNT-A; Dysport®) on the clinical characteristics of cervical dystonia (CD). Background: The pharmacologic effects of…
  • 2017 International Congress

    Clinical Relevance of Treatment With OnabotulinumtoxinA in Patients With Cervical Dystonia: Results From the CD Probe Study

    K. Dashtipour, Z. Mari, J. Jankovic, C. Adler, M. Schwartz, M. Brin (Loma Linda, CA, USA)

    Objective: To explore minimal clinically important change perceived by patients as beneficial by the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) using data from the…
  • 2017 International Congress

    Oromandibular dystonia (OMD): A Prospective, Single-Blind Trial of AbobotulinumtoxinA (AboA)

    S. Factor, M. Silver, J. Hanfelt, E. Sperine, L. Scorr, A. Freeman, H. Jinnah (Atlanta, GA, USA)

    Objective: To examine the safety and efficacy of AboA in OMD Background: OMD causes involuntary movements of the lower facial, masticatory, and lingual muscles.  The…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 23
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley